![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 21600 |
FusionGeneSummary for MEF2D_SORL1 |
![]() |
Fusion gene information | Fusion gene name: MEF2D_SORL1 | Fusion gene ID: 21600 | Hgene | Tgene | Gene symbol | MEF2D | SORL1 | Gene ID | 4209 | 6653 |
Gene name | myocyte enhancer factor 2D | sortilin related receptor 1 | |
Synonyms | - | C11orf32|LR11|LRP9|SORLA|SorLA-1|gp250 | |
Cytomap | 1q22 | 11q24.1 | |
Type of gene | protein-coding | protein-coding | |
Description | myocyte-specific enhancer factor 2DMADS box transcription enhancer factor 2, polypeptide D | sortilin-related receptorLDLR relative with 11 ligand-binding repeatslow-density lipoprotein receptor relative with 11 ligand-binding repeatsmosaic protein LR11sortilin-related receptor, L(DLR class) A repeats containingsorting protein-related recept | |
Modification date | 20180523 | 20180527 | |
UniProtAcc | Q14814 | Q92673 | |
Ensembl transtripts involved in fusion gene | ENST00000464356, ENST00000348159, ENST00000353795, ENST00000340875, ENST00000368240, ENST00000360595, | ENST00000260197, ENST00000532451, ENST00000525532, ENST00000532694, ENST00000534286, ENST00000527934, | |
Fusion gene scores | * DoF score | 9 X 5 X 6=270 | 11 X 10 X 6=660 |
# samples | 8 | 10 | |
** MAII score | log2(8/270*10)=-1.75488750216347 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/660*10)=-2.72246602447109 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: MEF2D [Title/Abstract] AND SORL1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | MEF2D | GO:0045944 | positive regulation of transcription by RNA polymerase II | 20590529 |
Tgene | SORL1 | GO:0006605 | protein targeting | 16407538 |
Tgene | SORL1 | GO:0006622 | protein targeting to lysosome | 24523320 |
Tgene | SORL1 | GO:0006892 | post-Golgi vesicle-mediated transport | 17855360 |
Tgene | SORL1 | GO:0014910 | regulation of smooth muscle cell migration | 14764453 |
Tgene | SORL1 | GO:0032091 | negative regulation of protein binding | 16407538 |
Tgene | SORL1 | GO:0034067 | protein localization to Golgi apparatus | 17855360 |
Tgene | SORL1 | GO:0045053 | protein retention in Golgi apparatus | 17855360 |
Tgene | SORL1 | GO:0045732 | positive regulation of protein catabolic process | 24523320 |
Tgene | SORL1 | GO:0051604 | protein maturation | 17855360 |
Tgene | SORL1 | GO:1902430 | negative regulation of amyloid-beta formation | 16407538|22621900 |
Tgene | SORL1 | GO:1902960 | negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process | 16407538 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LGG | TCGA-TM-A84J-01A | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000464356 | ENST00000260197 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
intron-intron | ENST00000464356 | ENST00000532451 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
intron-intron | ENST00000464356 | ENST00000525532 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
intron-intron | ENST00000464356 | ENST00000532694 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
intron-intron | ENST00000464356 | ENST00000534286 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
intron-intron | ENST00000464356 | ENST00000527934 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-3CDS | ENST00000348159 | ENST00000260197 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000348159 | ENST00000532451 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000348159 | ENST00000525532 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000348159 | ENST00000532694 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000348159 | ENST00000534286 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000348159 | ENST00000527934 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-3CDS | ENST00000353795 | ENST00000260197 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000353795 | ENST00000532451 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000353795 | ENST00000525532 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000353795 | ENST00000532694 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000353795 | ENST00000534286 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000353795 | ENST00000527934 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-3CDS | ENST00000340875 | ENST00000260197 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000340875 | ENST00000532451 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000340875 | ENST00000525532 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000340875 | ENST00000532694 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000340875 | ENST00000534286 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000340875 | ENST00000527934 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-3CDS | ENST00000368240 | ENST00000260197 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000368240 | ENST00000532451 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000368240 | ENST00000525532 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000368240 | ENST00000532694 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000368240 | ENST00000534286 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
5UTR-intron | ENST00000368240 | ENST00000527934 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
intron-3CDS | ENST00000360595 | ENST00000260197 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
intron-intron | ENST00000360595 | ENST00000532451 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
intron-intron | ENST00000360595 | ENST00000525532 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
intron-intron | ENST00000360595 | ENST00000532694 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
intron-intron | ENST00000360595 | ENST00000534286 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
intron-intron | ENST00000360595 | ENST00000527934 | MEF2D | chr1 | 156470278 | - | SORL1 | chr11 | 121424646 | + |
Top |
FusionProtFeatures for MEF2D_SORL1 |
![]() |
Hgene | Tgene |
MEF2D | SORL1 |
Transcriptional activator which binds specifically tothe MEF2 element, 5'-YTA[AT](4)TAR-3', found in numerous muscle-specific, growth factor- and stress-induced genes. Mediatescellular functions not only in skeletal and cardiac muscledevelopment, but also in neuronal differentiation and survival.Plays diverse roles in the control of cell growth, survival andapoptosis via p38 MAPK signaling in muscle-specific and/or growthfactor-related transcription. Plays a critical role in theregulation of neuronal apoptosis (By similarity). {ECO:0000250,ECO:0000269|PubMed:10849446, ECO:0000269|PubMed:11904443,ECO:0000269|PubMed:12691662, ECO:0000269|PubMed:15743823,ECO:0000269|PubMed:15834131}. | Likely to be a multifunctional endocytic receptor, thatmay be implicated in the uptake of lipoproteins and of proteases.Binds LDL, the major cholesterol-carrying lipoprotein of plasma,and transports it into cells by endocytosis. Binds the receptor-associated protein (RAP). Could play a role in cell-cellinteraction. Involved in APP trafficking to and from the Golgiapparatus. It probably acts as a sorting receptor that protectsAPP from trafficking to late endosome and from processing intoamyloid beta, thereby reducing the burden of amyloidogenic peptideformation. Involved in the regulation of smooth muscle cellsmigration, probably through PLAUR binding and decreasedinternalization. {ECO:0000269|PubMed:14764453,ECO:0000269|PubMed:16174740}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for MEF2D_SORL1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for MEF2D_SORL1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
MEF2D | YWHAQ, HDAC5, HDAC4, EP300, CABIN1, NFATC2, SP1, MAPK7, MEF2A, SNCA, CARM1, PRMT5, MAPK14, COPS5, HDAC3, KAT2B, SENP3, PRKACA, ASH2L, MEN1, RBBP5, KMT2D, HIRA, HDAC1, ASCL1, APP, CDK6, SHMT2, MOV10, NXF1, SKP2, FUS, XPO1, JUN, DNMT3L, MEF2B | SORL1 | LRPAP1, GGA1, GGA2, PPP1CA, CUL1, COPS5, COPS6, FBXO6, CFTR, DYRK3, POP1, AURKA, APP, PACS1, FAM76B, HLA-DPA1, RSPO1, LGALS8, FGL1, LGALS9, DLD, FOSL2, WISP3, SP6, ZFP41, FOXI2, ZNF354C, TYW3, ZNF563, ZNF224, ZNF408, ZNF331, EGFL6, ZNF169, FAM19A3, OS9, ZBBX, ZNF517, ZNF264, PSG1, SREBF1, MDK, SCGB1D1, ZNF816, FAM19A4, SOST, CDHR5, ZNF549, GCNT3, CEP97 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MEF2D_SORL1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for MEF2D_SORL1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | MEF2D | C0338480 | Common Migraine | 1 | CTD_human |
Tgene | SORL1 | C0008370 | Cholestasis | 1 | CTD_human |
Tgene | SORL1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Tgene | SORL1 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |